You are here:

Healthcare & Life Sciences

The rapid-changing regulatory environment and the specific needs for protection and commercialization of the key business assets in the healthcare & life sciences sector call for comprehensive advice based on extensive expertise. We have made it our mission to deliver you with inspiring solutions to tackle your challenges and allow your business to thrive.

Our clients range from med-tech and bio-tech companies, all the way to pharmaceutical leaders, investors, suppliers, cure and care institutions, insurers, governmental bodies and healthcare real estate developers.

Full range of services

Our full-service offer integrates a regulatory, legal and tax approach, with a particular focus on:

  • Private and public M&A, including private equity;
  • Equity and debt financing;
  • Joint-ventures and collaborations, including R&D;
  • Protection and commercialization of intellectual property assets;
  • Contracts related to development, manufacturing and distribution of regulated products;
  • Regulatory requirements, authorizations and proceedings;
  • Employment, general corporate governance and restructurings;
  • Swiss and international direct tax and VAT.

Advice beyond borders

Our global dedicated healthcare & life sciences team consists of 40 attorneys at law and tax advisors working together to provide leading expertise across a wide range of disciplines. We bring together expertise in commercial, corporate, tax, regulatory, intellectual property, competition, data protection, and employment matters. Combined with monitoring market developments, this allows us to provide advice in a proactive and pragmatic manner, enabling you to capitalize on business opportunities.

Local knowledge in our home jurisdictions and the EU combined with cross-border expertise: that is what we can offer you to ensure first-class advice.

What you can expect

  • In-depth knowledge of the sector, your business model, and future developments;
  • Creative answers and solutions from a tight-knit team;
  • Pragmatic, clear, concise and well-thought-out advice;
  • Responsive service with short delivery time frames;
  • Competitive fees based on our extensive track record and specialization; and
  • A strong commitment to a mutually beneficial long-term partnership.
Life Sciences Bit Tightened Swiss regulatory requirements in relation to international pharmaceuticals trading
News - 06 May 2021 - Switzerland

Life Sciences Bit: Tightened Swiss regulatory requirements

Swiss wholesale license holder must tighten their audit practices towards suppliers from countries outside of the EU.
read more
Due Diligence For Swiss CBD Companies
Article - 24 March 2021 - Switzerland

Due Diligence for Swiss CBD Companies

Switzerland has proven to provide for attractive conditions for businesses involved in the production and distribution of cannabidiol (CBD) products.
read more
Event - 22 December 2020 - Switzerland

Webinar on legal aspects of scaling up your business and attracting external funding

If you are an entrepreneur in the life sciences, pharma or healthcare industry and you aim to attract external funding to develop and grow your business or you...
read more
News - 09 April 2020 - Luxembourg

Loyens & Loeff Luxembourg has advised EQT VIII Fund

Loyens & Loeff Luxembourg has advised EQT VIII Fund which has entered into exclusive negotiations to acquire Schülke & Mayr GmbH (“schülke”).
read more
  1. 1
  2. 2
  3. 3
  4. next page